Lv6
2490 积分 2022-07-07 加入
De-Escalation Strategies With Immune Checkpoint Blockers in Non–Small Cell Lung Cancer: Do We Already Have Enough Evidence?
1天前
已完结
Dose-reduction trials in oncology — aiming for less toxicity and better quality of life at lower costs
1天前
已完结
The Drug-Dosing Conundrum in Oncology — When Less Is More
1天前
已完结
MYC in cancer: from undruggable target to clinical trials
2天前
已完结
Genomic and fragmentomic landscapes of cell-free DNA for early cancer detection
3天前
已完结
Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions
5天前
已完结
Sotorasib’s Accelerated Approval
8天前
已完结
Opportunities for Artificial Intelligence in Oncology: From the Lens of Clinicians and Patients
12天前
已关闭
ALK in cancer: from function to therapeutic targeting
16天前
已完结
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial
16天前
已完结
皖公网安备34019202002308
